Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.

BACKGROUND Eclampsia, the occurrence of a seizure (fit) in association with pre-eclampsia, is rare but potentially life-threatening. Magnesium sulphate is the drug of choice for treating eclampsia. This review assesses its use for preventing eclampsia. OBJECTIVES To assess the effects of magnesium sulphate, and other anticonvulsants, for prevention of eclampsia. SEARCH STRATEGY We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (4 June 2010), and the Cochrane Central Register of Controlled Trials Register (The Cochrane Library 2010, Issue 3). SELECTION CRITERIA Randomised trials comparing anticonvulsants with placebo or no anticonvulsant, or comparisons of different drugs, for pre-eclampsia. DATA COLLECTION AND ANALYSIS Two authors assessed trial quality and extracted data independently. MAIN RESULTS We included 15 trials. Six (11,444 women) compared magnesium sulphate with placebo or no anticonvulsant: magnesium sulphate more than a halved the risk of eclampsia (risk ratio (RR) 0.41, 95% confidence interval (CI) 0.29 to 0.58; number needed to treat for an additional beneficial outcome (NNTB) 100, 95% CI 50 to 100), with a non-significant reduction in maternal death (RR 0.54, 95% CI 0.26 to 1.10) but no clear difference in serious maternal morbidity (RR 1.08, 95% CI 0.89 to 1.32). It reduced the risk of placental abruption (RR 0.64, 95% CI 0.50 to 0.83; NNTB 100, 95% CI 50 to 1000), and increased caesarean section (RR 1.05, 95% CI 1.01 to 1.10). There was no clear difference in stillbirth or neonatal death (RR 1.04, 95% CI 0.93 to 1.15). Side effects, primarily flushing, were more common with magnesium sulphate (24% versus 5%; RR 5.26, 95% CI 4.59 to 6.03; number need to treat for an additional harmful outcome (NNTH) 6, 95% CI 5 to 6).Follow-up was reported by one trial comparing magnesium sulphate with placebo: for 3375 women there was no clear difference in death (RR 1.79, 95% CI 0.71 to 4.53) or morbidity potentially related to pre-eclampsia (RR 0.84, 95% CI 0.55 to 1.26) (median follow-up 26 months); for 3283 children exposed in utero there was no clear difference in death (RR 1.02, 95% CI 0.57 to 1.84) or neurosensory disability (RR 0.77, 95% CI 0.38 to 1.58) at age 18 months.Magnesium sulphate reduced eclampsia compared to phenytoin (three trials, 2291 women; RR 0.08, 95% CI 0.01 to 0.60) and nimodipine (one trial, 1650 women; RR 0.33, 95% CI 0.14 to 0.77). AUTHORS' CONCLUSIONS Magnesium sulphate more than halves the risk of eclampsia, and probably reduces maternal death. There is no clear effect on outcome after discharge from hospital. A quarter of women report side effects with magnesium sulphate.

[1]  D. Henderson-smart,et al.  Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. , 2014, The Cochrane database of systematic reviews.

[2]  D. Henderson-smart,et al.  Drugs for treatment of very high blood pressure during pregnancy. , 2013, The Cochrane database of systematic reviews.

[3]  S. Brophy,et al.  Interventions for latent autoimmune diabetes (LADA) in adults. , 2011, The Cochrane database of systematic reviews.

[4]  D. Chou,et al.  Magnesium sulphate versus diazepam for eclampsia. , 2010, The Cochrane database of systematic reviews.

[5]  D. Henderson-smart,et al.  Magnesium sulphate versus phenytoin for eclampsia. , 2010, The Cochrane database of systematic reviews.

[6]  D. Chou,et al.  Magnesium sulphate versus lytic cocktail for eclampsia. , 2010, The Cochrane database of systematic reviews.

[7]  L. Duley,et al.  Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. , 2010, The Cochrane database of systematic reviews.

[8]  Robert N. Taylor,et al.  Subclinical hypothyroidism after pre-eclampsia , 2009, BMJ : British Medical Journal.

[9]  A. Muhammad,et al.  O643 Low dose magnesium sulfate in the control of eclamptic fits: A randomized control trial , 2009 .

[10]  B. Winikoff,et al.  O645 Preeclampsia in low‐resource settings: A randomized trial of IV MgSO4 via flow controlled pump , 2009 .

[11]  K. Begum.  O108 A lower dose of magnesium sulphate for control of convulsion in eclamptic women of Bangladesh , 2009 .

[12]  L. Duley,et al.  Magpie Trial in the UK: methods and additional data for women and children at 2 years following pregnancy complicated by pre-eclampsia , 2009, BMC pregnancy and childbirth.

[13]  Marilyn J. Cipolla,et al.  Magnesium Sulfate for the Treatment of Eclampsia: A Brief Review , 2009, Stroke.

[14]  J. Chowdhury,et al.  Comparison of intramuscular magnesium sulfate with low dose intravenous magnesium sulfate regimen for treatment of eclampsia , 2009, The journal of obstetrics and gynaecology research.

[15]  L. Doyle,et al.  Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus ( Review ) , 2022 .

[16]  K. Lim,et al.  Phenytoin Versus Magnesium Sulfate in Preeclampsia: A Pilot Study , 1993, American journal of perinatology.

[17]  J. Villar,et al.  Reducing eclampsia-related deaths—a call to action , 2008, The Lancet.

[18]  D. Lewis,et al.  Prostacyclin and Thromboxane Levels in Women with Severe Preeclampsia Undergoing Magnesium Sulfate Therapy During Antepartum and Postpartum Periods , 2008, Hypertension in pregnancy.

[19]  S. Saha,et al.  Safety and efficacy of low‐dose MgSO4 in the treatment of eclampsia , 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[20]  L. Doyle,et al.  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years , 2006, BJOG : an international journal of obstetrics and gynaecology.

[21]  D. Altman,et al.  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months , 2006, BJOG : an international journal of obstetrics and gynaecology.

[22]  B. Mercer,et al.  Abbreviated Postpartum Magnesium Sulfate Therapy for Women With Mild Preeclampsia: A Randomized Controlled Trial , 2006, Obstetrics and gynecology.

[23]  Lelia Duley,et al.  Cost‐effectiveness of prophylactic magnesium sulphate for 9996 women with pre‐eclampsia from 33 countries: economic evaluation of the Magpie Trial , 2006, BJOG : an international journal of obstetrics and gynaecology.

[24]  G. Saade,et al.  Oral labetalol given to treated non hypertensive patients with preeclampsia is no more likely to cause hypotension than magnesium sulfate , 2005 .

[25]  L. Groome,et al.  A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy. , 2005, American journal of obstetrics and gynecology.

[26]  D. Henderson-smart,et al.  Interventions for preventing pre‐eclampsia and its consequences: generic protocol , 2005 .

[27]  O. Abudu,et al.  Eclampsia: A Randomized Double Blind Trial of Magnesium Sulphate and Diazepam in Lagos, Nigeria , 2005 .

[28]  A. Ghahiri,et al.  A Comparison between Intravenous Magnesium Sulfate and Oral Magnesium Chloride in Mild Preeclampsia , 2005 .

[29]  B. Mercer,et al.  Abbreviated post-partum magnesium sulfate therapy for women with mild preeclampsia , 2004 .

[30]  R. Smyth.  The Magpie Trial follow up study: outcome after discharge from hospital for women and children recruited to a trial comparing magnesium sulphate with placebo for pre-eclampsia [ISRCTN86938761] , 2004, BMC pregnancy and childbirth.

[31]  D. Lewis,et al.  Effects of magnesium sulfate on prostacyclin and thromboxane in women with severe preeclampsia , 2003 .

[32]  N. Hollenberg.  A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. , 2003, Current hypertension reports.

[33]  J. Squires,et al.  The Asq User's Guide for the Ages & Stages Questionnaires - a Parent-completed, Child-monitoring System , 2003 .

[34]  B. Sibai,et al.  Magnesium Sulfate in Women With Mild Preeclampsia: A Randomized Controlled Trial , 2003, Obstetrics and gynecology.

[35]  G. Saade,et al.  A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. , 2003, The New England journal of medicine.

[36]  L. Duley,et al.  Interventionist versus expectant care for severe pre-eclampsia before term. , 2002, The Cochrane database of systematic reviews.

[37]  A. Begum,et al.  Loading dose versus standard regime of magnesium sulfate in the management of eclampsia: A randomized trial , 2002 .

[38]  S. Sheth,et al.  Magnesium for preventing and treating eclampsia: time for international action , 2002, The Lancet.

[39]  D. Altman,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[40]  H. P. Jones,et al.  The Health Status Questionnaire: achieving concordance with published disability criteria , 2002, Archives of disease in childhood.

[41]  B. Sibai,et al.  16 Magnesium sulfate in women with mild preeclampsia: A double-blind, placebo-controlled trial , 2001 .

[42]  A. Begum,et al.  A low dose (‘Dhaka’) magnesium sulphate regime for eclampsia , 2001, Acta obstetricia et gynecologica Scandinavica.

[43]  A. Bertini,et al.  Tratamento da Eclâmpsia: Estudo Comparativo entre o Sulfato de Magnésio e a Fenitoína , 2000 .

[44]  B. Khoshnood,et al.  Perinatal Death and Tocolytic Magnesium Sulfate , 2000, Obstetrics and gynecology.

[45]  M. Møller,et al.  Comparison of Magnesium and Methyldopa for the Control of Blood Pressure in Pregnancies Complicated with Hypertension , 2000, Gynecologic and Obstetric Investigation.

[46]  L. Yinglin,et al.  A comparison of phentolamine and magnesium sulfate therapy in pre‐eclampsia , 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[47]  D. Henderson-smart,et al.  Plasma volume expansion for treatment of pre‐eclampsia , 1999 .

[48]  Michael A. Varner,et al.  Change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulfate in patients with preeclampsia. , 1999, American journal of obstetrics and gynecology.

[49]  J. Neilson,et al.  Magnesium sulphate and pre-eclampsia , 1999, BMJ.

[50]  R. Pattinson,et al.  A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre‐eclampsia , 1999, British journal of obstetrics and gynaecology.

[51]  J. Al,et al.  Efficacy of isosorbide in aerosol form in the management of hypertensive crisis in severe preeclampsia , 1998 .

[52]  M. Li,et al.  [The effect of nimodipine on retinal blood flow in pregnancy induced hypertension]. , 1998, Zhonghua fu chan ke za zhi.

[53]  R. Rush,et al.  A randomised controlled trial of intravenous magnesium sulphate versus placebo , 1998, British journal of obstetrics and gynaecology.

[54]  J. Guillebaud,et al.  Editor's Choice: Menorrhagia and endometrial ablation , 1998, British journal of obstetrics and gynaecology.

[55]  K. Leveno,et al.  Does magnesium sulfate given for prevention of eclampsia affect the outcome of labor? , 1998, American journal of obstetrics and gynecology.

[56]  A. Gülmezoglu,et al.  Use of anticonvulsants in eclampsia and pre-eclampsia: survey of obstetricians in the United Kingdom and Republic of Ireland , 1998, BMJ.

[57]  E. Coetzee,et al.  A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre‐eclampsia , 1998, British journal of obstetrics and gynaecology.

[58]  B. Khoshnood,et al.  Is tocolytic magnesium sulphate associated with increased total paediatric mortality? , 1997, The Lancet.

[59]  A. Witlin,et al.  The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial. , 1997, American journal of obstetrics and gynecology.

[60]  L. Duley.  Magnesium sulphate regimens for women with eclampsia: messages from the Collaborative Eclampsia Trial , 1996, British journal of obstetrics and gynaecology.

[61]  J. Hauth,et al.  Does magnesium sulfate affect the length of labor induction in women with pregnancy-associated hypertension? , 1995, American journal of obstetrics and gynecology.

[62]  K. Leveno,et al.  A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. , 1995, The New England journal of medicine.

[63]  R. Collins,et al.  WHICH ANTICONVULSANT FOR WOMEN WITH ECLAMPSIA - EVIDENCE FROM THE COLLABORATIVE ECLAMPSIA TRIAL , 1995 .

[64]  Shuenn-Dyh Chang,et al.  Expectant management in severe preeclampsia: does magnesium sulfate prevent the development of eclampsia? , 1995, Acta obstetricia et gynecologica Scandinavica.

[65]  K. Nelson,et al.  Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? , 1995, Pediatrics.

[66]  C. Redman,et al.  Eclampsia in the United Kingdom , 1994, BMJ.

[67]  J. Moodley,et al.  Intravenous and intramuscular magnesium sulphate regimens in severe pre-eclampsia. , 1994, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[68]  L. Duley,et al.  Magnesium sulphate for pre‐eclampsia and eclampsia: the evidence so far , 1994, British journal of obstetrics and gynaecology.

[69]  P. Rubin,et al.  Are anticonvulsants necessary to prevent eclampsia? , 1994, The Lancet.

[70]  M. Belfort,et al.  Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: A randomized, placebo‐controlled study , 1993, American journal of obstetrics and gynecology.

[71]  W. Rj,et al.  Anticonvulsant treatment in severe preeclampsia. Comparison between diazepam and magnesium sulfate , 1992 .

[72]  G. Saade,et al.  The effect of magnesium sulfate on maternal retinal blood flow in preeclampsia: a randomized placebo-controlled study. , 1992, American journal of obstetrics and gynecology.

[73]  L. Duley.  Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean , 1992, British journal of obstetrics and gynaecology.

[74]  M. Raebel,et al.  Magnesium sulfate versus phenytoin for seizure prophylaxis in pregnancy-induced hypertension. , 1991, American journal of obstetrics and gynecology.

[75]  P. Mcnair,et al.  The effect of magnesium on maternal blood pressure in pregnancy‐induced hypertension A randomized double‐blind placebo‐controlled trial , 1991, Acta obstetricia et gynecologica Scandinavica.

[76]  J. Junge,et al.  Magnesium supplement in pregnancy‐induced hypertension , 1990, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[77]  B. Sibai.  Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. , 1990, American journal of obstetrics and gynecology.

[78]  M. Sadeh,et al.  Action of magnesium sulfate in the treatment of preeclampsia-eclampsia. , 1989, Stroke.

[79]  R. Lilford,et al.  PHENYTOIN IN PRE-ECLAMPSIA , 1989, The Lancet.

[80]  J. Maheshwari,et al.  Anti-convulsant therapy in eclampsia. , 1989, Journal of Postgraduate Medicine.

[81]  S. Finkbeiner,et al.  Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure. , 1988, The New England journal of medicine.

[82]  J. Pritchard,et al.  The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. , 1984, American journal of obstetrics and gynecology.

[83]  F. Zuspan.  Problems encountered in the treatment of pregnancy-induced hypertension. A point of view. , 1978, American journal of obstetrics and gynecology.

[84]  Thankam R. Varma.  CHLORMETHIAZOLE IN THE TREATMENT OF PRE‐ECLAMPSIA , 1972, British Journal of Obstetrics and Gynaecology.

[85]  J. Pritchard.  The use of the magnesium ion in the management of eclamptogenic toxemias. , 1955, Surgery, gynecology & obstetrics.

[86]  A. Begum.  Loading dose vs standard regime of magnesium sulphate in the management of eclampsia — A randomized trial , 2002, The journal of obstetrics and gynaecology research.

[87]  L. Doyle,et al.  Magnesium sulphate for preventing preterm birth in threatened preterm labour. , 2002, The Cochrane database of systematic reviews.

[88]  L. Bricker.  The magpie trial: Magnesium sulphate versus placebo for women with pre‐eclampsia , 2000 .

[89]  A. Gülmezoglu,et al.  Anticonvulsants for women with pre-eclampsia. , 2000, The Cochrane database of systematic reviews.

[90]  S. Selvin,et al.  Magnesium sulfate tocolysis and risk of neonatal death. , 1998, American journal of obstetrics and gynecology.

[91]  G. Dekker,et al.  Comparison of the effectivity and safety of ketanserin versus dihydralazine in the treatment of severe early-onset peeclampsia , 1995 .

[92]  J. Moodley,et al.  Prophylactic Anticonvulsant Therapy in Hypertensive Crises of Pregnancy—The Need for a Large, Randomized Trial , 1994 .

[93]  Jean Golding,et al.  Geographic variation in incidence of hypertension in pregnancy , 1988 .